Can-Fite BioPharma Initiating a 1-for-3,000 Reverse Share Split; ADSs Tumble

Dow Jones

2025/12/24

By Stephen Nakrosis

Can-Fite BioPharma's American depositary shares slid after its board of directors approved a 1-for-3,000 reverse share split.

The ADSs were down 29% to 17 cents each in post-market trading on Tuesday. The ADSs retreated in the regular trading session 1.7% to close at 24 cents after touching a 52-week low earlier in the day. Year to date, the ADSs have declined 85%.

Concurrently with the reverse split, Can-Fite will change the ratio of ordinary shares underlying its ADSs, from one ADS representing 300 ordinary shares to one ADS representing two ordinary shares. For holders of the company's ADSs, the ratio change will have the same effect as a 1-for-20 ADS split, according to Can-Fite. No adjustment will be made to the outstanding number of the company's ADSs, Can-Fite added.

The company's shares will begin trading on a reverse stock split adjusted basis on Jan. 5.

Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

(END) Dow Jones Newswires

December 23, 2025 17:30 ET (22:30 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2593533446"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2593533446\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2593533446?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-24 06:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2593533446","market":"sg","top_or_hot":-1,"title":"Can-Fite BioPharma Initiating a 1-for-3,000 Reverse Share Split; ADSs Tumble","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Stephen Nakrosis \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Can-Fite BioPharma's American depositary shares slid after its board of directors approved a 1-for-3,000 reverse share split. \n</p>\n<p>\n  The ADSs were down 29% to 17 cents each in post-market trading on Tuesday. The ADSs retreated in the regular trading session 1.7% to close at 24 cents after touching a 52-week low earlier in the day. Year to date, the ADSs have declined 85%. \n</p>\n<p>\n  Concurrently with the reverse split, Can-Fite will change the ratio of ordinary shares underlying its ADSs, from one ADS representing 300 ordinary shares to one ADS representing two ordinary shares. For holders of the company's ADSs, the ratio change will have the same effect as a 1-for-20 ADS split, according to Can-Fite. No adjustment will be made to the outstanding number of the company's ADSs, Can-Fite added. \n</p>\n<p>\n  The company's shares will begin trading on a reverse stock split adjusted basis on Jan. 5. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Stephen Nakrosis at stephen.nakrosis@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 23, 2025 17:30 ET (22:30 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can-Fite BioPharma Initiating a 1-for-3,000 Reverse Share Split; ADSs Tumble</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan-Fite BioPharma Initiating a 1-for-3,000 Reverse Share Split; ADSs Tumble\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-12-24 06:30</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Stephen Nakrosis \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Can-Fite BioPharma's American depositary shares slid after its board of directors approved a 1-for-3,000 reverse share split. \n</p>\n<p>\n  The ADSs were down 29% to 17 cents each in post-market trading on Tuesday. The ADSs retreated in the regular trading session 1.7% to close at 24 cents after touching a 52-week low earlier in the day. Year to date, the ADSs have declined 85%. \n</p>\n<p>\n  Concurrently with the reverse split, Can-Fite will change the ratio of ordinary shares underlying its ADSs, from one ADS representing 300 ordinary shares to one ADS representing two ordinary shares. For holders of the company's ADSs, the ratio change will have the same effect as a 1-for-20 ADS split, according to Can-Fite. No adjustment will be made to the outstanding number of the company's ADSs, Can-Fite added. \n</p>\n<p>\n  The company's shares will begin trading on a reverse stock split adjusted basis on Jan. 5. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Stephen Nakrosis at stephen.nakrosis@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 23, 2025 17:30 ET (22:30 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CANF","symbol_name":"Can-Fite Biopharma Ltd","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2593533446","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2593533446","pubTimestamp":1766529000,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Can-Fite BioPharma's American depositary shares slid after its board of directors approved a 1-for-3,000 reverse share split.The ADSs were down 29% to 17 cents each in post-market trading on Tuesday. The ADSs retreated in the regular trading session 1.7% to close at 24 cents after touching a 52-week low earlier in the day. Year to date, the ADSs have declined 85%.Concurrently with the reverse split, Can-Fite will change the ratio of ordinary shares underlying its ADSs, from one ADS representing 300 ordinary shares to one ADS representing two ordinary shares. For holders of the company's ADSs, the ratio change will have the same effect as a 1-for-20 ADS split, according to Can-Fite. No adjustment will be made to the outstanding number of the company's ADSs, Can-Fite added.The company's shares will begin trading on a reverse stock split adjusted basis on Jan. 5.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CANF":"Can-Fite Biopharma Ltd","BK4139":"生物科技"},"translate_title":"Can-Fite BioPharma启动3,000股1股的反向股票分割；ADSs翻滚","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CANF":0.9},"content_text":"By Stephen Nakrosis \n\n\n \n\n\n  Can-Fite BioPharma's American depositary shares slid after its board of directors approved a 1-for-3,000 reverse share split. \n\n\n  The ADSs were down 29% to 17 cents each in post-market trading on Tuesday. The ADSs retreated in the regular trading session 1.7% to close at 24 cents after touching a 52-week low earlier in the day. Year to date, the ADSs have declined 85%. \n\n\n  Concurrently with the reverse split, Can-Fite will change the ratio of ordinary shares underlying its ADSs, from one ADS representing 300 ordinary shares to one ADS representing two ordinary shares. For holders of the company's ADSs, the ratio change will have the same effect as a 1-for-20 ADS split, according to Can-Fite. No adjustment will be made to the outstanding number of the company's ADSs, Can-Fite added. \n\n\n  The company's shares will begin trading on a reverse stock split adjusted basis on Jan. 5. \n\n\n \n\n\n  Write to Stephen Nakrosis at stephen.nakrosis@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 23, 2025 17:30 ET (22:30 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}